[go: up one dir, main page]

FI894546A7 - Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi

Info

Publication number
FI894546A7
FI894546A7 FI894546A FI894546A FI894546A7 FI 894546 A7 FI894546 A7 FI 894546A7 FI 894546 A FI894546 A FI 894546A FI 894546 A FI894546 A FI 894546A FI 894546 A7 FI894546 A7 FI 894546A7
Authority
FI
Finland
Prior art keywords
halomethylidene
ethynyladenosine
ethenylidene
derivatives
novel
Prior art date
Application number
FI894546A
Other languages
English (en)
Swedish (sv)
Other versions
FI94763B (fi
FI94763C (fi
FI894546A0 (fi
Inventor
James R Mccarthy
Michael L Edwards
David M Stemerick
Esa T Jarvi
Nellikunja J Prakash
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI894546A0 publication Critical patent/FI894546A0/fi
Publication of FI894546A7 publication Critical patent/FI894546A7/fi
Publication of FI94763B publication Critical patent/FI94763B/fi
Application granted granted Critical
Publication of FI94763C publication Critical patent/FI94763C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI894546A 1988-09-27 1989-09-26 Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi FI94763C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24991188A 1988-09-27 1988-09-27
US24991188 1988-09-27
US38939189A 1989-08-03 1989-08-03
US38939189 1989-08-03

Publications (4)

Publication Number Publication Date
FI894546A0 FI894546A0 (fi) 1989-09-26
FI894546A7 true FI894546A7 (fi) 1990-03-28
FI94763B FI94763B (fi) 1995-07-14
FI94763C FI94763C (fi) 1995-10-25

Family

ID=26940460

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894546A FI94763C (fi) 1988-09-27 1989-09-26 Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi

Country Status (18)

Country Link
EP (1) EP0365849B1 (fi)
JP (1) JP2968002B2 (fi)
KR (1) KR0146333B1 (fi)
CN (1) CN1046334A (fi)
AR (1) AR248283A1 (fi)
AT (1) ATE111477T1 (fi)
AU (1) AU621664B2 (fi)
CA (1) CA1336903C (fi)
DE (1) DE68918215T2 (fi)
DK (1) DK171237B1 (fi)
ES (1) ES2063796T3 (fi)
FI (1) FI94763C (fi)
HU (1) HU204843B (fi)
IE (1) IE63561B1 (fi)
IL (1) IL91773A (fi)
NO (1) NO171857C (fi)
NZ (1) NZ230766A (fi)
PT (1) PT91803B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206244A (en) * 1990-10-18 1993-04-27 E. R. Squibb & Sons, Inc. Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
US5340816A (en) * 1990-10-18 1994-08-23 E. R. Squibb & Sons, Inc. Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
AU662630B2 (en) * 1992-05-12 1995-09-07 Aventis Inc. A process for the preparation of ribonucleotide reductase inhibitors
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
US5627053A (en) * 1994-03-29 1997-05-06 Ribozyme Pharmaceuticals, Inc. 2'deoxy-2'-alkylnucleotide containing nucleic acid
WO1996001834A1 (en) * 1994-07-12 1996-01-25 Yamasa Corporation 2'-deoxy-2'-(substituted or unsubstituted methylidene)-4'-thionucleoside
WO2000074686A1 (en) * 1999-06-09 2000-12-14 Anticancer, Inc. Modulators of methylation for control of bacterial virulence
US6579857B1 (en) 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
JP2005522443A (ja) * 2002-02-14 2005-07-28 フアーマセツト・リミテツド 改変フッ素化ヌクレオシド類似体
UA117095C2 (uk) 2011-12-22 2018-06-25 Аліос Біофарма, Інк. Нуклеозидна сполука або її фармацевтично прийнятна сіль
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0267878A1 (en) * 1986-11-14 1988-05-18 Ciba-Geigy Ag N9-cyclopentyl-substituted adenine derivatives
EP0310673B1 (en) * 1987-03-19 1995-07-05 Yamasa Shoyu Kabushiki Kaisha 2'-alkylidenepyrimidine nucleoside derivatives, process for their preparation, and their use
NZ225906A (en) * 1987-08-26 1990-10-26 Merrell Dow Pharma Aristeromycin/adenosine derivatives and pharmaceutical compositions
ZA894534B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Novel neplanocin derivatives

Also Published As

Publication number Publication date
NO893826L (no) 1990-03-28
HUT50844A (en) 1990-03-28
NO171857C (no) 1993-05-12
ATE111477T1 (de) 1994-09-15
FI94763B (fi) 1995-07-14
NO171857B (no) 1993-02-01
AU4176089A (en) 1990-04-05
HU204843B (en) 1992-02-28
DE68918215T2 (de) 1995-02-02
EP0365849A2 (en) 1990-05-02
DE68918215D1 (de) 1994-10-20
PT91803B (pt) 1995-05-31
IL91773A0 (en) 1990-06-10
DK473289D0 (da) 1989-09-26
CN1046334A (zh) 1990-10-24
KR900004736A (ko) 1990-04-12
IL91773A (en) 1994-02-27
EP0365849B1 (en) 1994-09-14
JPH02160769A (ja) 1990-06-20
NO893826D0 (no) 1989-09-26
AU621664B2 (en) 1992-03-19
DK171237B1 (da) 1996-08-05
ES2063796T3 (es) 1995-01-16
JP2968002B2 (ja) 1999-10-25
EP0365849A3 (en) 1990-12-27
FI94763C (fi) 1995-10-25
PT91803A (pt) 1990-03-30
KR0146333B1 (ko) 1998-08-01
IE893080L (en) 1990-03-27
FI894546A0 (fi) 1989-09-26
CA1336903C (en) 1995-09-05
AR248283A1 (es) 1995-07-12
DK473289A (da) 1990-03-28
IE63561B1 (en) 1995-05-17
NZ230766A (en) 1992-07-28

Similar Documents

Publication Publication Date Title
FI891338A0 (fi) Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi
NO894539D0 (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
FI903752A7 (fi) Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
FI894546A7 (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
MX9203459A (es) Nuevos derivados de 2'-halometilideno, 2'-etenilideno y 2'-etinilcitidina, uridina y guanosina.
FI896075A7 (fi) Menetelmä 4,5,6,7-tetrahydrobentsimidatsolijohdosten valmistamiseksi
FI890186A7 (fi) Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
FI895662A0 (fi) Menetelmä 3,4-difluorisubstituoidun benseenin valmistamiseksi
FI892946A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi
FI890185A7 (fi) Menetelmä 1-alkyyli-5-nitroimidatsolien valmistamiseksi
FI893682L (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
FR2630735B1 (fr) Procede de preparations d'halogenophenols
FI900145L (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
FI890188A7 (fi) Menetelmä 1-hydroksialkyyli-2-metyyli-5-nitroimidatsolien valmistamiseksi
NO891985D0 (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
FI891111A7 (fi) Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi
HU8902302D0 (en) Process for preparation of 1,2-hydroxy-phosphonates and derivatives thereof
FI904673A0 (fi) 2,6-dioksopiperidiinijohdannaisten valmistus
FI93010B (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
FR2603282B1 (fr) Derives d'isoquinoleine
FI92393B (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
EP0267537A3 (en) Process for the preparation of vinylglyoxal derivatives, vinylglyoxal derivatives and their use
FI942678A0 (fi) Menetelmä 3'-deoksi-3-'fluorimetyylinukleosidijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: MERRELL DOW PHARMACEUTICALS INC.

MA Patent expired